These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 26597958)
1. Modulation of NF-κB Signaling as a Therapeutic Target in Autoimmunity. Herrington FD; Carmody RJ; Goodyear CS J Biomol Screen; 2016 Mar; 21(3):223-42. PubMed ID: 26597958 [TBL] [Abstract][Full Text] [Related]
2. Bidirectional regulation of nuclear factor-κB and mammalian target of rapamycin signaling functionally links Bnip3 gene repression and cell survival of ventricular myocytes. Dhingra R; Gang H; Wang Y; Biala AK; Aviv Y; Margulets V; Tee A; Kirshenbaum LA Circ Heart Fail; 2013 Mar; 6(2):335-43. PubMed ID: 23395931 [TBL] [Abstract][Full Text] [Related]
3. NF-κB: At the Borders of Autoimmunity and Inflammation. Barnabei L; Laplantine E; Mbongo W; Rieux-Laucat F; Weil R Front Immunol; 2021; 12():716469. PubMed ID: 34434197 [TBL] [Abstract][Full Text] [Related]
4. Direct Rel/NF-κB inhibitors: structural basis for mechanism of action. Ouk S; Liou ML; Liou HC Future Med Chem; 2009 Dec; 1(9):1683-707. PubMed ID: 21425986 [TBL] [Abstract][Full Text] [Related]
5. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains. Düwel M; Welteke V; Oeckinghaus A; Baens M; Kloo B; Ferch U; Darnay BG; Ruland J; Marynen P; Krappmann D J Immunol; 2009 Jun; 182(12):7718-28. PubMed ID: 19494296 [TBL] [Abstract][Full Text] [Related]
6. NF-kappa B as a therapeutic target in autoimmune disease. O'Sullivan B; Thompson A; Thomas R Expert Opin Ther Targets; 2007 Feb; 11(2):111-22. PubMed ID: 17227228 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies. Thomas RK; Sos ML; Zander T; Mani O; Popov A; Berenbrinker D; Smola-Hess S; Schultze JL; Wolf J Clin Cancer Res; 2005 Nov; 11(22):8186-94. PubMed ID: 16299251 [TBL] [Abstract][Full Text] [Related]
8. [Ubiquitins, proteasomes, sumoylation and therapeutic application today and in future for cancer and other diseases. I. Ubiquitin-proteasome system and the transcription factor NF-kappaB]. Fuchs O; Neuwirtová R Vnitr Lek; 2006 Apr; 52(4):371-8. PubMed ID: 16755993 [TBL] [Abstract][Full Text] [Related]
9. Novel non-peptide small molecules preventing IKKβ/NEMO association inhibit NF-κB activation in LPS-stimulated J774 macrophages. De Falco F; Di Giovanni C; Cerchia C; De Stefano D; Capuozzo A; Irace C; Iuvone T; Santamaria R; Carnuccio R; Lavecchia A Biochem Pharmacol; 2016 Mar; 104():83-94. PubMed ID: 26776306 [TBL] [Abstract][Full Text] [Related]
10. Targeting the NF-κB pathway in cancer therapy. Erstad DJ; Cusack JC Surg Oncol Clin N Am; 2013 Oct; 22(4):705-46. PubMed ID: 24012396 [TBL] [Abstract][Full Text] [Related]
11. IKKbeta programs to turn on the GADD45alpha-MKK4-JNK apoptotic cascade specifically via p50 NF-kappaB in arsenite response. Song L; Li J; Zhang D; Liu ZG; Ye J; Zhan Q; Shen HM; Whiteman M; Huang C J Cell Biol; 2006 Nov; 175(4):607-17. PubMed ID: 17116751 [TBL] [Abstract][Full Text] [Related]
12. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production. Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510 [TBL] [Abstract][Full Text] [Related]
13. Delineating role of ubiquitination on nuclear factor-kappa B pathway by a computational modeling approach. Lee J; Choi K; Choi C Biochem Biophys Res Commun; 2010 Jan; 391(1):33-7. PubMed ID: 19895789 [TBL] [Abstract][Full Text] [Related]
14. TNFR1-activated NF-κB signal transduction: regulation by the ubiquitin/proteasome system. Wertz IE Curr Opin Chem Biol; 2014 Dec; 23():71-7. PubMed ID: 25461388 [TBL] [Abstract][Full Text] [Related]
15. Proteasome inhibitors induce inhibitory kappa B (I kappa B) kinase activation, I kappa B alpha degradation, and nuclear factor kappa B activation in HT-29 cells. Németh ZH; Wong HR; Odoms K; Deitch EA; Szabó C; Vizi ES; Haskó G Mol Pharmacol; 2004 Feb; 65(2):342-9. PubMed ID: 14742676 [TBL] [Abstract][Full Text] [Related]
16. The activation of the NF-κB-JNK pathway is independent of the PI3K-Rac1-JNK pathway involved in the bFGF-regulated human fibroblast cell migration. Xuan Y; Chi L; Tian H; Cai W; Sun C; Wang T; Zhou X; Shao M; Zhu Y; Niu C; Sun Y; Cong W; Zhu Z; Li Z; Wang Y; Jin L J Dermatol Sci; 2016 Apr; 82(1):28-37. PubMed ID: 26829882 [TBL] [Abstract][Full Text] [Related]
17. Nuclear Factor-kappaB in Autoimmunity: Man and Mouse. Miraghazadeh B; Cook MC Front Immunol; 2018; 9():613. PubMed ID: 29686669 [TBL] [Abstract][Full Text] [Related]